Compliance with Antiplatelet Therapy in Pts with Ischemic CVD:Assessment by Platelet Aggregation Testing
Stroke 25:2337-2342, Komiya,T.,et al, 1994
Patent Foramen Ovale and Brain Infarct:Echocardiographic Predictors, Recurrence, and Prevention
Stroke 25:782-786, Hanna,J.P.,et al, 1994
Clinicopath Conf
Leucocytoclastic Vasculitis, Due to Staphylococcal Protein A Column Therapy with CVA, Case 35-1994,, EJM1:792-800,1994., 1994
Stroke and Transient Ischaemic Attacks
JNNP 57:534-543, Humphrey,P., 1994
Stroke:The Way Things Really Are
Stroke 25:1290-1294, Scheinberg,P., 1994
Immediate Anticoagulation with Heparin for First-Ever Ischemic Stroke in Carotid Artery Territ within 5 Hr
Arch Neurol 51:462-467, Camerlingo,M.,et al, 1994
A Follow-up Survey of Clinical Practices for the Use of Heparin, Warafarin, & Aspirin
Neurol 44:618-621, Alberts,M.J.,et al, 1994
Atrial Fibrillation and Stroke:Revisiting the Dilemmas
Stroke 25:1337-1341, Hart,R.G.&Halperin,J.L., 1994
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Ann Int Med 120:897-902, Hylek,E.M.&Singer,D.E., 1994
Susac's Syndrome:Triad of Microangiopathy of the Brain and Retina with Hearing Loss in Young Women
Neurol 44:591-593, Susac,J.O., 1994
Medical Treatment for Stroke Prevention
Ann Int Med 121:41-55, Matchar,D.B.,et al, 1994
Cladribine in Treatment of Chronic Progressive Multiple Sclerosis
Lancet 344:3-13, Sipe,J.C.,et al, 1994
Cost-Effectiveness of Ticlopidine in Preventing Stroke in High-Risk Patients
Stroke 25:1149-1156, 10971994., Oster,G.,et al, 1994
Thrombocytopenia in Association with Adjunctive Felbamate Use
Neurol 44:980-981, Ney,G.C.,et al, 1994
Eval of Back Pain Secondary to Spinal Epidural Hematoma Assoc with Aspirin Intake & Partial Platelet Glycopr Def
Arch Int Med 154:2769-2771, Franscini,L.,et al, 1994
Guidelines for the Management of Transient Ischemic Attacks
Stroke 25:1320-1335, Feinberg,W.M.,et al, 1994
Guidelines for the Management of Patients with Acute Ischemic Stroke
Stroke 25:1901-1914, Adams,H.P.,et al, 1994
Warfarin Versus Aspirin for Prevention of Thromboembolism in Atrial Fibrillation:SPAF II Study
SPAF-II Investigators, Lancet 343:687-691, 683994., , 1994
Failure of Aspirin Treatment After Stroke
Stroke 25:275-277, Bornstein,N.M.,et al, 1994
Embolic Stroke After Unanticoagulated Cardioversion Despite Prior Exclusion of Atrial Thrombi by TEE
Eur Heart J 15:1279-1280, Missault,L.,et al, 1994
The Acquired Immunodeficiency Syndrome in Older Persons
West J Med 161:526, Rozance,C.P.&Kizer,K.W., 1994
How Twin Cities Neurologists Treat Ischemic Stroke, Policies and Trends
Arch Neurol 50:1098-1103, Anderson,D.C., 1993
Secondary Prevention in Non-Rheumatic Atrial Fib After TIA or Minor Stroke
European Atrial Fibrillation Trial Study Group, Lancet 342:1255-1262, 1251-1252993., , 1993
Topical Aspirin in Chloroform and the Relief of Pain Due to Herpes Zoster and Postherpetic Neuralgia
Arch Neurol 50:1046-1053, King,R.B., 1993
Clinical Features of Recurrent Embolization in Acute Cardioembolic Stroke
Stroke 24:1681-1685, Yasaka,M.,et al, 1993
Ischemic & Hemorrhagic Stroke in Pts on Oral Anticoagulants After Reconstruct for Chronic Lower Limb Ischemia
Stroke 24:1655-1663, Dawson,I.,et al, 1993
Safety of Anticoagulation After Hemorrhagic Infarction
Neurol 43:1298-1303, Pessin,M.S.,et al, 1993
Coagulation Abnormalities and Cerebral Infarction
JNNP 56:433-439, Greaves,M., 1993
Complications of Therapy for Venous Thromboembolic Disease in Patients with Brain Tumors
Neurol 43:1111-1114, Levin,J.M.,et al, 1993
The Antiphospholipid Syndrome:Ten years On
Lancet 342:341-344, Hughes,G.R.V., 1993
Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy
NEJM 329:696-702, Eckman,M.H.,et al, 1993
Anticoagulant-Related Bleeding:Clinical Epidemiology, Prediction, and Prevention
Am J Med 95:315-328, Landefeld,C.S.&Beyth,R.J., 1993
Deep Cerebral Venous System Thrombosis:Case Report
Neurosurgery 33:911-913, Brown,J.I.M.,et al, 1993
Efficacy of Ticlopidine & Aspirin for Prev of Rev Cerebrovascular Ischemic Events, Ticlopidine Aspirin Study
Stroke 24:1452-1457, Bellavance,A.,et al, 1993
Risk Factors for Complications of Chronic Anticoagulation
Ann Int Med 118:511-520, Fihn,S.D.,et al, 1993
Antithrombotic Therapy in Acute Ischaemic Stroke:An Overviews of the Completed Randomized Trials
JNNP 56:17-25, Sandercock,P.A.G.,et al, 1993
The Efficacy & Safety of Ticlopidine & Aspirin in Non-Whites:Subgroup from Ticlopidine Aspirin Stroke Study
Neurol 43:27-31, Weisberg,L.A., 1993
Laboratory Monitoring of Oral Anticoagulant Therapy:Are We Being Misled?
Neurol 43:468-470, Albers,G.W., 1993
Creutzfeldt-Jakob Disease and Blood Transfusion
lancet 341:205-207, Esmonde,T.F.G.,et al, 1993
Transient Neurologic and Ocular Manifestations in Primary Thrombocythemia
Neurol 43:1107-1110, Michiels,J.J.,et al, 1993
Does Low-Dose ASA Prevent Stroke After Carotid Surgery? A Double-blind, Placebo-controlled Randomized Trial
Stroke 24:1125-1128, Lindblad,B.,et al, 1993
Effect of Low-Intensity Warfarin Anticoag on Level of Activity of Hemostatic System in Pts with Atrial Fib
Stroke 24:1360-1365, Kistler,J.P.,et al, 1993
Acute Compartment Syndromes Resulting from Anticoagulant Treatment
BMJ 305:1474-1475, Hay,S.M.,et al, 1992
Risk FActors for Central Nervous System Manifest of Gastroenteritis-Associated Hemolytic-Uremic Syndrome
Pediatrics 90:616-621, Cimolai,N.,et al, 1992
Failure of High-Dose Heparin to Prevent Recurr Cardioembolic Strokes in Preg Pt with Mech Heart Valve
Neurol 42:2204-2206, Golby,A.J.,et al, 1992
Chronic Myelopathy Associated with Human T-Lymphotropic Virus Type I (HTLV-I)
Ann Int Med 117:933-946, Gessain,A.&Gout,O., 1992
Anticoagulant Treatment as a Risk Factor for Primary Intracerebral Hemorrhage
JNNP 55:1121-1124, Fogelholm,R.,et al, 1992
Cost Effectiveness of Primary Stroke Prevention in Atrial Fibrillation
BMJ 305:1457-1460, 14451992., Gustafsson,C.,et al, 1992
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
NEJM 327:1406-1412, 14511992., Ezekowitz,M.D.,et al, 1992
Stroke Complic Acute MI, A Meta-Analysis of Risk Modific by Antigoac & Thrombolytic Therapy
Arch Int Med 152:2020-2024, Viatkus,P.T.,et al, 1992